Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
Ryotaro BouchiTakahiro SugiyamaAtsushi GotoMitsuru OhsugiNarihito YoshiokaHideki KatagiriTomoya MitaYushi HirotaHiroshi IkegamiMunehide MatsuhisaEiichi ArakiHiroki YokoyamaMasae MinamiKatsuya YamazakiHideaki JinnouchiHiroki IkedaHitomi FujiiMiyuki NogawaMasahiro KaneshigeKengo MiyoKohjiro UekiPublished in: Journal of diabetes investigation (2023)
Our data suggest that glycemic control did not deteriorate during the COVID-19 pandemic with appropriate intensification of diabetes treatment in patients with diabetes who continued to attend specialized diabetes care facilities, and that patients and physicians shared the same expectations and concerns about telemedicine.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- end stage renal disease
- weight loss
- insulin resistance
- primary care
- cross sectional
- chronic kidney disease
- ejection fraction
- prognostic factors
- palliative care
- peritoneal dialysis
- patient reported outcomes
- big data
- adipose tissue
- metabolic syndrome
- deep learning
- clinical trial